HLA and CTLA4 polymorphisms may confer a synergistic risk in the susceptibility to Graves disease

Journal of Human Genetics

Volumn 55, Issue 5, 2010, Pages 323-326

  Takahashi, Megumi ^a   Kimura, Akinori ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

CTLA4; Grave's disease; HLA

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA ANTIGEN; HLA DPB1 ANTIGEN; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY;

ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CTLA4 GENE; DNA POLYMORPHISM; GENE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GRAVES DISEASE; HLA GENE; HLA SYSTEM; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY;

ANTIGENS, CD; ASIAN CONTINENTAL ANCESTRY GROUP; EPISTASIS, GENETIC; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GRAVES DISEASE; HLA ANTIGENS; HLA-A ANTIGENS; HLA-DP ANTIGENS; HUMANS; JAPAN; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 77952794423     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1038/jhg.2010.20     Document Type: Article

References (17)

1. Zakarija, M & McKenzie, J M Clinical review 3: the clinical use of thyrotropin receptor antibody measurements. J. Clin. Endocrinol. Metab. 69, 1093-1096 (1989).
2. Mukuta, T., Tamai, H., Oshima, A., Morita, T., Matsubayashi, S., Fukata, S. et al. Immunological findings and thyroid function of untreated Graves' disease patients with undetectable TSH-binding inhibitor immunoglobulin. Clin. Endocrinol. (Oxf) 40, 215-219 (1994).
3. Kawai, K., Tamai, H., Mori, T., Morita, T., Matsubayashi, S., Katayama, S. et al. Thyroid histology of hyperthyroid Graves' disease with undetectable thyrotropin receptor antibodies. J. Clin. Endocrinol. Metab. 77, 716-719 (1993).
4. Hemminki, K., Shu, X., Li, X., Ji, J., Sundquist, K. & Sundquist, J. Familial risks for hospitalized Graves' disease and goiter. Eur. J. Endocrinol. 161, 623-629 (2009).
5. Reveille, J. D. The genetic basis of autoantibody production. Autoimmun. Rev. 5, 389-398 (2006).
6. Jacobson, E. M., Huber, A. & Tomer, Y. The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J. Autoimmun. 30, 58-62 (2008).
7. Saito, S., Ota, S., Yamada, E., Inoko, H. & Ota, M. Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population. Tissue Antigens 56, 522-529 (2000).
8. Dong, R. P., Kimura, A., Okubo, R., Shinagawa, H., Tamai, H., Nishimura, Y. et al. HLA-A and DPB1 loci confer susceptibility to Graves' disease. Hum. Immunol. 35, 165-172 (1992).
9. Takahashi, M., Yasunami, M., Kubota, S., Tamai, H. & Kimura, A. HLA-DPB1*0202 is associated with a predictor of good prognosis of Graves' disease in the Japanese. Hum. Immunol. 67, 47-52 (2006).
10. Ueda, H., Howson, . J M., Esposito, L, Heward, J, Snook, H, Chamberlain, G et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423, 506-511 (2003). (Pubitemid 36648570)
11. Scalapino, K. J. & Daikh, D. I. CTLA-4: a key regulatory point in the control of autoimmune disease. Immunol. Rev. 223, 143-155 (2008).
12. Fife, B. T. & Bluestone, J. A. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. Immunol. Rev. 224, 166-182 (2008).
13. Kawoura, F. K., Akamizu, T., Awata, T., Ban, Y., Chistiakov, D. A., Frydecka, I. et al. Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis. J. Clin. Endocrinol. Metab. 92, 3162-3170 (2007).
14. Ban, Y., Tozaki, T., Taniyama, M., Tomita, M. & Ban, Y. Association of a CTLA-4 3¢ untranslated region (CT60) single nucleotide polymorphism with autoimmune thyroid disease in the Japanese population. Autoimmunity 38, 151-153 (2005). (Pubitemid 40872739)
15. Furugaki, K., Shirasawa, S., Ishikawa, N., Ito, K., Ito, K., & Kubota, S. Association of the T-cell regulatory gene CTLA4 with Graves' disease and autoimmune thyroid disease in the Japanese. J. Hum. Genet. 49, 166-168 (2004).
16. Downie-Doyle, S., Bayat, N., Rischmueller, M. & Lester, S. Influence of CTLA4 haplotypes on susceptibility and some extraglandular manifestations in primary Sjö-gren's syndrome. Arthritis Rheum. 54, 2434-2440 (2006).
17. Svejgaard, A. & Ryder, L. P. HLA and disease associations: detecting the strongest association. Tissue Antigens 43, 18-27 (1994).